Work

Interim safety and efficacy results from a phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.2526

Authors: D. E. Avigan, D. J. George, P. W. Kantoff, R. A. Figlin, D. W. Kufe, T. E. Olencki, M. J. Vasconcelles, B. S. Vasir, Y. Xu, R. M. Bukowski

Institutions: Beth Israel Deaconess Medical Center, Cleveland Clinic, University of California, Los Angeles, Dana-Farber Cancer Institute

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598801401

Cites:

Cited by: 11

Related to: 10